12:00 AM
Dec 09, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Lorus completes follow-on

Lorus Therapeutics Inc. (TSX: LOR; Pink:LRUSF), Toronto, Ontario
Business: Cancer, Gene/Cell therapy

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >